(Q36576467)
Statements
Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling (English)
Mathew T Mizwicki
Milan Fiala
Larry Magpantay
Najib Aziz
James Sayre
Guanghao Liu
Avi Siani
Derrick Chan
Otoniel Martinez-Maza
Madhuri Chattopadhyay
Antonio La Cava
21 November 2012